Methods for treatment of alport syndrome

• 收藏
• 分享

专利权人:

Regulus Therapeutics Inc.

发明人:

Bhat Balkrishen,Duffield Jeremy,Mackenna Deidre

申请号：

NZ63059613

公开号：

NZ630596A

申请日:

2013.10.08

申请国别(地区):

NZ

年份:

2017

代理人:

摘要：

Disclosed is the use of a modified oligonucleotide in the manufacture of a medicament for the treatment of Alport Syndrome in a subject having or suspected of having Alport Syndrome, wherein the modified oligonucleotide consists of 12 to 25 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/